Lijuan Chen

Prof. Lijuan Chen


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2022 in ACS Omega
Verified
Journal Article
Open access
MSMingsong Shi
Mingsong Shi
TCTao Chen
Tao Chen
SWSiping Wei
Siping Wei
CZChenyu Zhao
Chenyu Zhao
XZXinyu Zhang
Xinyu Zhang
LCLijuan Chen
Lijuan Chen
Focal adhesion kinase (FAK) is a 125 kDa nonreceptor tyrosine kinase that plays an important role in many carcinomas. Thus, the targeting of FAK by small molecules is considered to be promising for cancer therapy. Some FAK inhibitors have been reported as potential anticancer drugs and have entered into clinical development; for example, VS-4718 is currently undergoing clinical trials. However, the lack of crystal structural data for the binding of VS-4718 with FAK has hindered the optimization of this anticancer agent. In this work, the VS-4718/FAK interaction model was obtained by molecular docking and molecular dynamics simulations. The binding free energies of VS-4718/FAK were also calculated using the molecular mechanics generalized Born surface area method. It was found that the aminopyrimidine group formed hydrogen bonds with the C502 residue of the hinge loop, while the D564 residue of the T-loop interacted with the amide group. In addition, I428, A452, V484, M499, G505, and L553 residues formed hydrophobic interactions with VS-4718. The obtained results therefore provide an improved understanding of the interaction between human FAK and VS-4718. Based on the obtained binding mechanism, 47 novel compounds were designed to target the adenosine 5'-triphosphate-binding pocket of human FAK, and ensemble docking was performed to assess the effects of these modifications on the inhibitor binding affinity. This work is also expected to provide additional insights into potential future target design strategies based on VS-4718.

19 March 2015 in Plant Cell Reports
Verified
Journal Article
Closed access
PDF file
LCLijuan Chen
Lijuan Chen
JLJian Liu
Jian Liu
FZFei-Fei Zhao
Fei-Fei Zhao
JLJing-Yi Li
Jing-Yi Li
SWSheng-Xuan Wang
Sheng-Xuan Wang
DXDehui Xi
Dehui Xi

25 September 2017 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
LHLinhong He
Linhong He
HPHeying Pei
Heying Pei
TLTingxuan Lan
Tingxuan Lan
MTMinghai Tang
Minghai Tang
CZChufeng Zhang
Chufeng Zhang
LCLijuan Chen
Lijuan Chen

1 September 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
LHLinhong He
Linhong He
DLDa Li
Da Li
CZChufeng Zhang
Chufeng Zhang
PBPeng Bai
Peng Bai
LCLijuan Chen
Lijuan Chen

5 September 2020 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
XQXiang Qiu
Xiang Qiu
HPHeying Pei
Heying Pei
HNHengfan Ni
Hengfan Ni
ZSZhengying Su
Zhengying Su
YLYong Li
Yong Li
LWLi Wan
Li Wan